These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15068802)

  • 1. Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry.
    Lee T; Hoofnagle AN; Kabuyama Y; Stroud J; Min X; Goldsmith EJ; Chen L; Resing KA; Ahn NG
    Mol Cell; 2004 Apr; 14(1):43-55. PubMed ID: 15068802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen-exchange mass spectrometry reveals activation-induced changes in the conformational mobility of p38alpha MAP kinase.
    Sours KM; Kwok SC; Rachidi T; Lee T; Ring A; Hoofnagle AN; Resing KA; Ahn NG
    J Mol Biol; 2008 Jun; 379(5):1075-93. PubMed ID: 18501927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEF pocket in p38α facilitates substrate selectivity and mediates autophosphorylation.
    Tzarum N; Komornik N; Ben Chetrit D; Engelberg D; Livnah O
    J Biol Chem; 2013 Jul; 288(27):19537-47. PubMed ID: 23671282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b.
    Chang CI; Xu BE; Akella R; Cobb MH; Goldsmith EJ
    Mol Cell; 2002 Jun; 9(6):1241-9. PubMed ID: 12086621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
    Burkhard KA; Chen F; Shapiro P
    J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions.
    Tanoue T; Maeda R; Adachi M; Nishida E
    EMBO J; 2001 Feb; 20(3):466-79. PubMed ID: 11157753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
    Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
    J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3.
    Liu S; Sun JP; Zhou B; Zhang ZY
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5326-31. PubMed ID: 16567630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking interactions induce exposure of activation loop in the MAP kinase ERK2.
    Zhou T; Sun L; Humphreys J; Goldsmith EJ
    Structure; 2006 Jun; 14(6):1011-9. PubMed ID: 16765894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping low-affinity/high-specificity peptide-protein interactions using ligand-footprinting mass spectrometry.
    Parker BW; Goncz EJ; Krist DT; Statsyuk AV; Nesvizhskii AI; Weiss EL
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21001-21011. PubMed ID: 31578253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
    Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
    Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping ERK2-MKP3 binding interfaces by hydrogen/deuterium exchange mass spectrometry.
    Zhou B; Zhang J; Liu S; Reddy S; Wang F; Zhang ZY
    J Biol Chem; 2006 Dec; 281(50):38834-44. PubMed ID: 17046812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modeling studies of yeast Mitogen-Activated Protein Kinases (MAPKS): structural motifs as a basis for specificity.
    Smith DL; Nilar SH
    Protein Pept Lett; 2010 Jun; 17(6):732-8. PubMed ID: 19995338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
    Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
    Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.
    Bellon S; Fitzgibbon MJ; Fox T; Hsiao HM; Wilson KP
    Structure; 1999 Sep; 7(9):1057-65. PubMed ID: 10508788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the DEF motif on phosphorylation of peptide substrates by ERK.
    Fernandes N; Allbritton NL
    Biochem Biophys Res Commun; 2009 Sep; 387(2):414-8. PubMed ID: 19615338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of docking motifs in MAP-kinases and nuclear receptors.
    Burgermeister E; Lanzendoerfer M; Scheuer W
    J Biomol Struct Dyn; 2003 Apr; 20(5):623-34. PubMed ID: 12643765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen exchange solvent protection by an ATP analogue reveals conformational changes in ERK2 upon activation.
    Lee T; Hoofnagle AN; Resing KA; Ahn NG
    J Mol Biol; 2005 Oct; 353(3):600-12. PubMed ID: 16185715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.